Safety and anti-diabetic effects of Glucolevel, a mixture of dry extract of leaves of the Juglans regia L, Olea europea L, Urtica dioica L and Atriplex halimus L were evaluated using in vivo and in vitro test systems. No sign of toxic effects (using LDH assay) were seen in cultured human fibroblasts treated with increasing concentrations of Glucolevel. Similar observations were seen in vivo studies using rats (LD50: 25 g/kg). Anti-diabetic effects were evidenced by the augmentation of glucose uptake by yeast cells (2-folds higher) and by inhibition of glucose intestinal absorption (∼49%) in a rat gut-segment. Furthermore, treatment with Glucolevel of Streptozotocin-induced diabetic rats for 2–3 weeks showed a significant reduction in glucose levels [above 400 ± 50 mg/dl to 210 ± 22 mg/dl (P < 0.001)] and significantly improved sugar uptake during the glucose tolerance test, compared with positive control. In addition, glucose levels were tested in sixteen human volunteers, with the recent onset of type 2 diabetes mellitus, who received Glucolevel tablets 1 × 3 daily for a period of 4 weeks. Within the first week of Glucolevel consumption, baseline glucose levels were significantly reduced from 290 ± 40 to 210 ± 20 mg/dl. At baseline, a subgroup of eleven of these subjects had glucose levels below 300 mg% and the other subgroup had levels ≥ 300 mg%. Clinically acceptable glucose levels were achieved during the 2–3 weeks of therapy in the former subgroup and during the 4th week of therapy in the latter subgroup. No side effect was reported. In addition, a significant reduction in hemoglobin A1C values (8.2 ± 1.03 to 6.9 ± 0.94) was found in six patients treated with Glucolevel. Results demonstrate safety, tolerability and efficacy of herbal combinations of four plants that seem to act differently but synergistically to regulate glucose-homeostasis.
Self-specific processes (SSPs) specify the self as an embodied subject and agent, implementing a functional self/nonself distinction in perception, cognition, and action. Despite recent interest, it is still undetermined whether SSPs are all-or-nothing or graded phenomena; whether they can be identified in neuroimaging data; and whether they can be altered through attentional training. These issues are approached through a neurophenomenological exploration of the sense-of-boundaries (SB), the fundamental experience of being an ‘I’ (self) separated from the ‘world' (nonself). The SB experience was explored in collaboration with a uniquely qualified meditation practitioner, who volitionally produced, while being scanned by magnetoencephalogram (MEG), three mental states characterized by a graded SB experience. The results were then partly validated in an independent group of 10 long-term meditators. Implicated neural mechanisms include right-lateralized beta oscillations in the temporo-parietal junction, a region known to mediate the experiential unity of self and body; and in the medial parietal cortex, a central node of the self's representational system. The graded nature as well as the trainable flexibility and neural plasticity of SSPs may hold clinical implications for populations with a disturbed SB.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.